Skip to main content

Table 1 Clinicopathological characteristics of training and test sets for STAD patients in datasets

From: Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets

Clinical factors

TCGA (%)

GSE84437 (%)

Stage

 I

43 (14.7)

n.d

 II

93 (31.7)

n.d

 III

126 (43.0)

n.d

 IV

31 (10.6)

n.d

T

 T1

16 (5.5)

11 (2.5)

 T2

62 (21.2)

38 (8.8)

 T3

140 (47.8)

92 (21.2)

 T4

75 (25.6)

292 (67.4)

N

 N0

95 (32.4)

80 (18.5)

 N1

74 (25.3)

188 (43.4)

 N2

66 (22.5)

132 (30.5)

 N3

58 (19.8)

33 (7.6)

M

 M0

273 (93.2)

n.d

 M1

20 (6.8)

n.d

Age

  <  = 60

99 (33.9)

194 (44.8)

  > 60

193 (66.1)

239 (55.2)

Gender

 Female

115 (39.2)

137 (31.6)

 Male

178 (60.8)

296 (68.4)